Search details
1.
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.
Nature
; 607(7917): 119-127, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35576972
2.
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
; 120(52): e2314808120, 2023 Dec 26.
Article
in English
| MEDLINE | ID: mdl-38134196
3.
Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications.
Gastroenterology
; 164(2): 272-288, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36155191
4.
Coffee and green tea consumption with the risk of COVID-19 among the vaccine recipients in Japan: a prospective study.
J Epidemiol
; 2024 Feb 10.
Article
in English
| MEDLINE | ID: mdl-38346747
5.
Development and validation of claims-based algorithms for identifying hospitalized patients with COVID-19 and their severity in 2020 and 2021.
J Epidemiol
; 2024 Mar 09.
Article
in English
| MEDLINE | ID: mdl-38462528
6.
Relapse of toxocariasis after completion of four-week treatment with albendazole.
J Infect Chemother
; 2024 Jan 17.
Article
in English
| MEDLINE | ID: mdl-38242286
7.
Relationship between carbapenem use and major diagnostic category in curative care beds: Analysis of a 2020 Japanese national administrative database.
J Infect Chemother
; 30(6): 562-566, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-37952842
8.
Cumulative antibiogram preparation among hospitals participating in the Japan Surveillance for Infection Prevention and Healthcare Epidemiology.
J Infect Chemother
; 30(5): 459-462, 2024 May.
Article
in English
| MEDLINE | ID: mdl-37940037
9.
Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole.
J Infect Chemother
; 2024 Feb 17.
Article
in English
| MEDLINE | ID: mdl-38369121
10.
Disease burden of main bacterial infections in Japan, 2015-2020: A population-level study.
J Infect Chemother
; 2024 Apr 23.
Article
in English
| MEDLINE | ID: mdl-38657704
11.
Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study.
J Infect Chemother
; 2024 Feb 11.
Article
in English
| MEDLINE | ID: mdl-38350510
12.
Autopsy of tetanus with foot gangrene as portal of entry.
J Infect Chemother
; 30(5): 450-453, 2024 May.
Article
in English
| MEDLINE | ID: mdl-37944699
13.
Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma.
J Infect Chemother
; 2024 Jan 17.
Article
in English
| MEDLINE | ID: mdl-38242284
14.
Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan.
J Infect Chemother
; 30(6): 488-493, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38042298
15.
Molecular Epidemiology of Escherichia coli Resistant to Carbapenems, Fluoroquinolones, and Aminoglycosides Isolated from One of the Largest Hospitals in Vietnam in 2014-2019.
Can J Infect Dis Med Microbiol
; 2024: 2711353, 2024.
Article
in English
| MEDLINE | ID: mdl-38328340
16.
Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis.
J Infect Dis
; 228(12): 1652-1661, 2023 12 20.
Article
in English
| MEDLINE | ID: mdl-37756608
17.
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.
Clin Infect Dis
; 76(8): 1403-1411, 2023 04 17.
Article
in English
| MEDLINE | ID: mdl-36477182
18.
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum ß-lactamase-producing Escherichia coli.
Antimicrob Agents Chemother
; 67(10): e0051023, 2023 10 18.
Article
in English
| MEDLINE | ID: mdl-37702483
19.
Remdesivir for the Treatment of Covid-19 - Final Report.
N Engl J Med
; 383(19): 1813-1826, 2020 11 05.
Article
in English
| MEDLINE | ID: mdl-32445440
20.
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N Engl J Med
; 382(24): 2327-2336, 2020 06 11.
Article
in English
| MEDLINE | ID: mdl-32275812